Established in 2009 and co-hosted by UC San Francisco, the prestigious Precision Medicine World Conference (PMWC) will be held online and free for the first time in a special, three-day meeting focused on the COVID-19 pandemic....
As COVID-19 spread across the US at the beginning of 2020, clinical care was disrupted at many levels including cancer clinics temporarily shutting their door....
The COVID-19 emergency has motivated the research community to reach inspiring new heights – many investigators have pivoted their programs to collectively take virtually every approach to study COVID-19 and SARS CoV-2, from mechanisms of infection to clinical treatment, therapy development, and population studies!...
I would like to cordially invite you to join me to discuss the 21st Century Healthcare Ecosystem Catalyzed by COVID-19. COVID-19 has made it clear that we need new healthcare structures to deliver fast and efficient clinical care....
Q: What drives precision medicine at the University of Pittsburg and why is it important to meet now in Pittsburgh to focus on precision medicine advancements? A: Pittsburgh hosts the largest academic payer-provider healthcare system (UPMC and University of Pittsburgh) in the United States. Combined with...
Q: Your team was the first to show it’s possible to extract T cells from a patient, multiply them to the billions in the lab, and infuse them back into the patient to seek and destroy particular diseased cells. What is the significance of this...
I recently had a discussion with Dr. Aleks Rajkovic, Chief Genomics Officer at UCSF Health and Chair of Track 3 at PMWC Silicon Valley Jan 21-24, 2020. He shared his views on the advancements of clinical genomics implementation in the clinical setting. Find the full...
Q: In your roles as Assistant Vice Chancellor and Chief Information Officer of UCLA Health Sciences, you are responsible for the health information technology strategic plan. What emerging healthcare technologies do you anticipate will have the greatest impact on the strategic plan in the next...
PMWC sat down with Dr. Theresa LaVallee, Vice President of Translational Medicine and Regulatory Affairs at the Parker Institute for Cancer Immunotherapy, to discuss the recent developments in immunotherapy and their impact on individualized healthcare. Find the full interview on our blog post. Following are...
Q: Immunotherapy is redefining how we treat cancer. How is this treatment approach impacting healthcare and in particular individualized medicine? A: Over the last couple of decades, we have been able to improve oncology treatment for late stage cancer patients. We have been able to...
